CardioVia’s ViaOne device helps treat cardiac arrhythmias, replacing conventional exposed needle methods that risk puncturing ...

Providers were reluctant to wade into hospital deals amid the uncertainty surrounding tariffs, regulatory changes and ...

Transcarent closed its acquisition of Accolade for approximately $621 million, the company said Tuesday.

Proprio’s Paradigm AI guidance platform displays real-time progress during surgery, replacing X-ray and CT scans.

VillageMD has turned out to be a challenging venture for Walgreens, which invested $5.2 billion in 2021 to take a majority ...

This forward-looking webinar explores how leading health systems are addressing affordability upstream to improve both ...

CVS has faced financial challenges, particularly in its Aetna insurance unit, which attracted the attention of investor ...

The Trump administration opted to boost Medicare Advantage rates more than the Biden administration originally offered.

Providence faces rising costs from new tariffs, leading to potential staff cuts, service reductions and supply rationing.

Leading pharmacy benefit managers are shifting away from lucractive rebates on biologic drugs and toward lower-cost ...

Interwell Health CEO Robert Sepucha said the kidney care space is moving past the funding frenzy from a few years back.

There were 122 funding deals in the first three months of 2025 compared with 137 deals in 2024, according to data from ...